DARGAN CHARLES K 4
4 · BIOLARGO, INC. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
DARGAN CHARLES K
Chief Financial Officer
Transactions
- Award
Option to Purchase Common Stock
2022-12-28+205,000→ 4,031,500 totalExercise: $0.17From: 2022-12-28Exp: 2032-12-28→ Common stock (205,000 underlying)
Footnotes (2)
- [F1]This Option was granted to Reporting Person to replace an option previously issued to compensate Reporting Person for services to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price and current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.
- [F2]Reflects the December 28, 2022, expiration of an option to purchase 410,000 shares.